Xero Limited (AU:XRO)
ASX:XRO
Want to see AU:XRO full AI Analyst Report?
Top Page
Xero Limited
(Sydney:XRO)
Select Model
Select Model
Rating:67Neutral
Price Target:
AU$80.00
▼(-2.42% Downside)
Action:Reiterated
Date:05/15/26
The score is driven primarily by strong financial performance (notably excellent cash generation and continued revenue scale) and a supportive earnings outlook with clear FY27 guidance. These positives are tempered by weak price trend signals (trading below major moving averages) and a relatively high valuation (P/E ~51) with no dividend yield provided.
Positive Factors
Cash generation
Xero’s operating cash flow (~A$1.0B) and free cash flow (~A$993M) in 2026 reflect sustained cash conversion since 2023. Consistent FCF supports product and AI investment, M&A or capital returns, reduces reliance on external funding and materially increases long-term financial flexibility.
Negative Factors
Rising debt / leverage
Net debt rising to ~A$2.14B marks a meaningful increase in leverage versus prior years. Higher indebtedness raises interest and refinancing exposure, constrains optionality on capital allocation, and increases vulnerability to any slowdown in cash generation or margin compression.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash generation
Xero’s operating cash flow (~A$1.0B) and free cash flow (~A$993M) in 2026 reflect sustained cash conversion since 2023. Consistent FCF supports product and AI investment, M&A or capital returns, reduces reliance on external funding and materially increases long-term financial flexibility.
Read all positive factors
Xero Limited (XRO) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$13.36B
Dividend YieldN/A
Average Volume (3M)753.32K
Price to Earnings (P/E)82.5
Beta (1Y)0.99
Revenue Growth27.32%
EPS Growth-30.84%
CountryAU
Employees4,356
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)1.06
Shares Outstanding170,599,260
10 Day Avg. Volume611,423
30 Day Avg. Volume753,320
Financial Highlights & Ratios
PEG Ratio-3.07
Price to Book (P/B)2.73
Price to Sales (P/S)5.01
P/FCF Ratio14.94
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$126.58Price Target Upside54.40% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
EPS Forecast (FY)1.35
Revenue Forecast (FY)AU$3.67B
Xero Limited Business Overview & Revenue Model
Company Description
Xero Limited, together with its subsidiaries, operates as a software as a service company in New Zealand, Australia, the United Kingdom, and internationally. The company offers Xero, an open platform that connects small businesses to a range of so...
How the Company Makes Money
Xero primarily makes money through recurring subscription revenue from customers who pay monthly or annual fees to use its cloud accounting platform. Subscription plans are typically tiered by features and usage, so revenue scales with the number ...
Xero Limited Earnings Call Summary
Earnings Call Date:May 13, 2026
(Q4-2026)
| % Change Since: |
Next Earnings Date:Nov 12, 2026
Earnings Call Sentiment Positive
The call presented a strong set of operating and financial results: double-digit revenue growth, expanding ARPC driven by payments (Melio), accelerating U.S. momentum, robust adjusted EBITDA and free cash flow generation, and rapid AI adoption and product launches. Near-term headwinds include the pro forma dilution of Rule of 40 from the Melio acquisition, Melio-related losses and SBC timing, headline gross margin compression from payments/media mix, and planned multiyear U.S. brand investment that will weight FY'27 results toward H2. Management provided clear guidance for FY'27 and a pathway to Melio breakeven and Rule of 40 recovery by FY'28, indicating confidence in execution and capital discipline.Positive Updates
Strong Top-Line Growth
Operating revenue grew 31% year-on-year to $2.75 billion in FY'26 (21% organic). Fiscal '27 revenue guidance is $3.62bn–$3.73bn, reflecting continued momentum and a pathway to more than doubling group revenue from FY'25 by FY'28.
Negative Updates
Rule of 40 Impacted by Melio (Pro Forma Below 40%)
Headline Rule of 40 was cited at 48.5%, but on a pro forma basis including Melio full-year impact the Rule of 40 fell to ~36%. Management expects to be back above the 40% Rule of 40 by FY'28, but the near-term metric is diluted by the acquisition.
Read all updates
Q4-2026 Updates
Positive
Negative
Strong Top-Line Growth
Operating revenue grew 31% year-on-year to $2.75 billion in FY'26 (21% organic). Fiscal '27 revenue guidance is $3.62bn–$3.73bn, reflecting continued momentum and a pathway to more than doubling group revenue from FY'25 by FY'28.
Read all positive updates
Company Guidance
Xero guided FY27 operating revenue of $3.62–$3.73 billion and adjusted EBITDA of $860–$920 million, noting the outcome will be driven by a mix of ARPC expansion and customer growth plus some initial AI monetization; the guide explicitly includes up to AUD 55 million of incremental U.S. brand spend, carries a higher H2 weighting (reflecting Melio phasing and normal seasonality), and is supported by strong payments momentum after pro forma payments revenue of roughly $535 million in FY26 (payments grew ~56% pro forma) and group TPV of $62 billion. Management reiterated a FY26 pro forma Rule of 40 of 36% and said they expect to be back above the Rule of 40 by FY28, with Melio targeted to hit run‑rate adjusted EBITDA breakeven in H2 FY28 (FY26 results: adjusted EBITDA $757 million, free cash flow $554 million, net debt just under $400 million).Xero Limited Financial Statement Overview
Summary
Income Statement
82
Very Positive
Balance Sheet
70
Positive
Cash Flow
88
Very Positive
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.96B | 1.91B | 1.57B | 1.40B | 1.12B |
| Gross Profit | 2.08B | 1.70B | 1.43B | 989.43M | 810.40M |
| EBITDA | 809.72M | 697.39M | 510.98M | 105.70M | 49.51M |
| Net Income | 179.98M | 207.03M | 160.21M | -113.53M | -9.11M |
Balance Sheet | |||||
| Total Assets | 9.17B | 4.06B | 2.95B | 2.33B | 2.35B |
| Cash, Cash Equivalents and Short-Term Investments | 1.95B | 2.12B | 1.53B | 1.05B | 870.02M |
| Total Debt | 2.14B | 1.22B | 1.22B | 1.07B | 949.03M |
| Total Liabilities | 3.72B | 2.06B | 1.56B | 1.34B | 1.31B |
| Stockholders Equity | 5.44B | 2.00B | 1.39B | 986.53M | 1.04B |
Cash Flow | |||||
| Free Cash Flow | 993.05M | 799.66M | 585.17M | 102.22M | -4.43M |
| Operating Cash Flow | 1.00B | 812.82M | 591.76M | 381.52M | 240.83M |
| Investing Cash Flow | -4.64B | -403.75M | -242.01M | -304.90M | -430.04M |
| Financing Cash Flow | 3.61B | -177.17M | -93.26M | -303.10M | -61.52M |
Xero Limited Technical Analysis
Negative
81.98
Price Trends
78.64
Negative
85.73
Negative
116.63
Negative
Market Momentum
-0.25
Positive
46.85
Neutral
40.86
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:XRO, the sentiment is Negative. The current price of 81.98 is above the 20-day moving average (MA) of 80.91, above the 50-day MA of 78.64, and below the 200-day MA of 116.63, indicating a bearish trend. The MACD of -0.25 indicates Positive momentum. The RSI at 46.85 is Neutral, neither overbought nor oversold. The STOCH value of 40.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:XRO.
Xero Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | AU$47.57M | 8.76 | 28.62% | 4.39% | 15.36% | 66.67% | |
69 Neutral | AU$973.53M | 12.19 | 17.13% | 1.85% | 11.63% | 1754.91% | |
68 Neutral | AU$9.77B | 32.83 | 31.77% | 0.83% | 14.48% | 6.31% | |
67 Neutral | AU$13.36B | 82.46 | 3.68% | ― | 27.32% | -30.84% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | AU$1.04B | 6.36 | 19.57% | 2.47% | -7.41% | -11.47% | |
47 Neutral | AU$12.33M | 3.78 | 85.44% | ― | 25.61% | ― |
* Technology Sector Average
AU:XRO
Xero Limited
78.35
-103.37
-56.88%
AU:HSN
Hansen Technologies Limited
4.78
-0.19
-3.92%
AU:TNE
Technology One Limited
29.84
-8.64
-22.46%
AU:RKN
Reckon Limited
0.42
-0.06
-12.50%
AU:IRE
IRESS Limited
5.66
-2.72
-32.43%
AU:JCS
JCurve Solutions Limited
0.04
<0.01
6.06%
Xero Limited Corporate Events
Xero Seeks ASX Quotation for Small Tranche of New Shares
May 1, 2026
Xero Limited has applied to the ASX for quotation of a small tranche of new ordinary fully paid shares. The company is seeking listing of 7,857 additional XRO securities that were issued in late March 2026, likely arising from the exercise of opti...
Xero Reports Lapse of Equity Incentive Securities, Trimming Future Dilution
Apr 13, 2026
Xero Limited has disclosed the cessation of several tranches of employee-related securities, including restricted stock units and options, after performance or vesting conditions were not met or became incapable of being satisfied. The lapsed inst...
Xero Seeks ASX Quotation for New Ordinary Shares
Mar 18, 2026
Xero Limited has applied for quotation on the ASX of 546,776 new ordinary fully paid shares, issued on 11 and 16 March 2026. The new securities arise from the exercise or conversion of existing options or other convertible securities, modestly inc...
Xero Seeks ASX Quotation for New Batch of Ordinary Shares
Mar 10, 2026
Xero Limited has applied for quotation on the ASX of a small batch of newly issued ordinary fully paid shares, totaling 19,434 securities. The shares, issued on several dates between mid-December 2025 and late February 2026, arise from the exercis...
Xero Sets Out Key FY27 Governance and Reporting Dates
Feb 22, 2026
Xero Limited has outlined its proposed key dates for the financial year ending 31 March 2027, giving investors and stakeholders a clear timetable for governance and reporting events. The schedule includes a 9 July 2026 deadline for director nomina...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.